# Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx

> **NCT02739958** · NA · COMPLETED · sponsor: **Mansoura University** · enrollment: 40 (actual)

## Conditions studied

- Cancer Larynx
- Total Laryngectomy

## Interventions

- **DRUG:** Propofol group
- **DRUG:** Isoflurane group

## Key facts

- **NCT ID:** NCT02739958
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2016-08-30
- **Final completion:** 2016-10-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02739958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02739958, "Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02739958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*